Peptides DB
Research-centric peptide and protocol reference hub
Study 16 of 16Lypressin literatureJournal of neurological surgery. Part B, Skull base · Observational2023

Long-Term Surgical Outcomes and Recurrence Risk Stratification in Rathke's Cleft Cysts: Proposal of a Novel Scoring System.

Recurrence of Rathke's cleft cysts occurs in 11.1% of patients after surgery, with preoperative arginine vasopressin deficiency being a significant predictor.

Read at Journal of neurological surgery. Part B, Skull baseAdd to compare

Where it sits

this study against the rest of the lypressin corpus
1
Preclinical
11
Observational · this one
0
Open-label
1
Randomised
3
Reviews

Summary and findings

This study assessed long-term surgical outcomes and recurrence predictors in patients with Rathke's cleft cysts (RCCs) who underwent surgery. A novel seven-point recurrence risk score was proposed based on clinical, radiological, and pathological variables. Recurrence occurred in 11.1% of patients after a median follow-up of 118.5 months.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Recurrence occurred in four patients (11.1%) after a median of 118.5 months.n=362023

Abstract

The authors’ words, as Journal of neurological surgery. Part B, Skull base supplied them

<h4>Background</h4>Rathke's cleft cysts (RCCs) are benign, nonneoplastic sellar lesions arising from Rathke's pouch remnants. Although surgery provides effective symptom relief, recurrence remains a major concern, and no validated tool exists to guide postoperative surveillance.<h4>Objective</h4>To assess long-term surgical outcomes, identify recurrence predictors, and propose a novel recurrence risk score for RCCs.<h4>Methods</h4>Patients with histopathologically confirmed RCCs who underwent surgery between January 2000 and December 2023 at a tertiary neurosurgical center were retrospectively analyzed. Clinical, radiological, and pathological variables were evaluated for recurrence prediction. A multivariate logistic regression model generated a seven-point risk score, validated through receiver operating characteristic analysis and Kaplan-Meier survival curves.<h4>Results</h4>Thirty-six patients (median age: 39.5 years; 55.6% female) were included, with a median follow-up of 100.5 months. Headache (72%) was the most frequent symptom, followed by visual and endocrine disturbances. Gross total resection was achieved in 75%. Recurrence occurred in four patients (11.1%) after a median of 118.5 months. Preoperative arginine vasopressin deficiency (AVP-D) independently predicted recurrence (OR: 8.84, <i>p</i>  = 0.040), while subtotal excision, inflammation, and squamous metaplasia showed borderline significance. The composite seven-point score demonstrated excellent discrimination (AUC: 0.957, <i>p</i>  = 0.003), with scores > 5 correlating with higher recurrence risk (log-rank <i>p</i>  = 0.011).<h4>Conclusion</h4>RCC recurrence is influenced by preoperative AVP-D, surgical extent, and cyst wall histopathology. The proposed risk score enables reliable recurrence stratification and may inform individualized postoperative surveillance strategies.

Background

Rathke's cleft cysts (RCCs) are benign lesions that can cause significant symptoms and require surgical intervention. Although surgery is effective for symptom relief, recurrence remains a concern, and there is a lack of validated tools for postoperative monitoring. This study aims to address these issues by evaluating long-term outcomes and establishing a scoring system for recurrence risk.

Methods

This retrospective analysis included patients with histopathologically confirmed RCCs who underwent surgery from January 2000 to December 2023 at a tertiary neurosurgical center. A total of 36 patients were included, with clinical, radiological, and pathological variables assessed for recurrence prediction. A multivariate logistic regression model was used to create a seven-point risk score, validated through receiver operating characteristic analysis and Kaplan-Meier survival curves.

Results

The primary endpoint indicated that recurrence occurred in four patients (11.1%) after a median of 118.5 months. The study found that preoperative arginine vasopressin deficiency (AVP-D) was a significant predictor of recurrence with an odds ratio of 8.84 (p = 0.040). The seven-point risk score showed excellent discrimination with an area under the curve of 0.957 (p = 0.003).

Interpretation

The findings suggest that preoperative AVP-D is a strong predictor of recurrence, which aligns with previous literature indicating the importance of hormonal factors in RCC outcomes. However, the clinical significance of the seven-point risk score needs further validation in larger cohorts. Limitations such as the small sample size and retrospective design may affect the robustness of these conclusions and their applicability in clinical practice.

Key findings

  • Recurrence occurred in four patients (11.1%) after a median of 118.5 months.
  • Gross total resection was achieved in 75%.
  • Preoperative arginine vasopressin deficiency (AVP-D) independently predicted recurrence (OR: 8.84, p = 0.040).
  • The composite seven-point score demonstrated excellent discrimination (AUC: 0.957, p = 0.003).
  • Scores > 5 correlated with higher recurrence risk (log-rank p = 0.011).

Limitations

  • small sample size of 36 patients
  • retrospective design may introduce bias
  • single-center study limits generalizability
  • no external validation of the scoring system

Elsewhere in the Lypressin corpus

BDiagnostic challenges of masked arginine vasopressin deficiency in neurosarcoidosis complicated by sodium-glucose cotransporter 2 inhibitor use.JCEM case reports · 2023 · n=1 · Not reported in abstract.HumanBDevelopment of a liquid chromatography coupled to tandem mass spectrometry method for the quantification of Arginine Vasopressin in human plasma.Clinica chimica acta; international journal of clinical chemistry · 2026 · validated over a concentration range from 0.2 ng/L to 60 ng/LHumanBNursing intensity trajectory patterns and clinical outcomes in intensive care units: a latent class analysis.International journal of nursing studies advances · 2026 · n=7334 · Rapid Improvement associated with 74% lower mortality odds (OR = 0.26, 95% CI: 0.18-0.36, p < 0.001).HumanDBeyond the pump: integrating the heart's endocrine function into early medical education.Medical education online · 2026reviewCIntegrated Phytochemical Characterisation, Pharmacological Evaluation and Computational Investigation of Acampe papillosa Stem Extract.Analytical science advances · 2026 · Rectal temperature reduced to 98.04 ± 0.05°F at 21 h post-treatment.AnimalDResearch progress on the role and mechanism of STIM and Orai protein-mediated store-operated calcium entry in cardiovascular diseases.Channels (Austin, Tex.) · 2026review